Although relatively rare, many childhood cancers remain life-threatening and lack effective personalized treatments. Rhabdoid tumors are among these fatal cancers and can develop in various tissues ...

Treatment With All-Trans Retinoic Acid and Anthracycline Monochemotherapy for Children With Acute Promyelocytic Leukemia: A Multicenter Study by the PETHEMA Group No survival differences were observed ...

Prognostic Value of Minimal Residual Disease Quantification Before Allogeneic Stem-Cell Transplantation in Relapsed Childhood Acute Lymphoblastic Leukemia: The ALL-REZ BFM Study Group Treatment was ...

Just a few weeks ago, Chatham Police Sergeant Mark Poani’s stepson, Graedy Skelton, passed away after his battle with cancer.

Atypical teratoid/rhabdoid tumours (ATRTs) represent an aggressive, rare paediatric malignancy of the central nervous system, predominantly affecting infants and young children. Characterised by the ...

Researchers from the Johns Hopkins University School of Medicine have hypothesized that LP-184 could synergize with the PARP inhibitor rucaparib, which avoids DNA repairing in tumor cells, for the ...

St. Jude Children's Research Hospital scientists reversed an aggressive cancer, reverting malignant cells towards a more normal state. Rhabdoid tumors are an aggressive cancer which is missing a key ...

A new study revealed how aberrant epigenetic regulation contributes to the development of atypical teratoid/rhabdoid (AT/RT) tumors, which are aggressive brain tumors that mainly affect young children ...

Jonny Terrell was a healthy, happy baby — but a month before his first birthday, he came down with an infection. Days later, he was vomiting. Over the next few weeks, mom Emily Robichau took him to ...

First author Sandi Radko-Juettner, PhD, a former St. Jude Graduate School of Biomedical Sciences student, now a Research Program Manager for the Hematological Malignancies Program and senior author ...